Novartis AG
Mesenchymal stem cell differentiation
Last updated:
Abstract:
The present invention provides for methods and compositions for treating or preventing arthritis and joint injury.
Status:
Grant
Type:
Utility
Filling date:
20 Dec 2019
Issue date:
8 Feb 2022